Background Current treatment plans for individuals with relapsed or refractory (RR) lymphoma and multiple myeloma (MM) are limited, highlighting the unmet dependence on effective therapies in these disease configurations. which enrolled sequentially the following: once daily (QD), after that intermittent twice (BIW) or thrice weekly (TIW) that enrolled concurrently, and lastly five times on/two times… Continue reading Background Current treatment plans for individuals with relapsed or refractory (RR)